Cargando…

The plasma levels of soluble ST2 as a marker of gut mucosal damage in early HIV infection

OBJECTIVE: Following tissue barrier breaches, interleukin-33 (IL-33) is released as an ‘alarmin’ to induce inflammation. Soluble suppression of tumorigenicity 2 (sST2), as an IL-33 decoy receptor, contributes to limit inflammation. We assessed the relationship between the IL-33/ST2 axis and markers...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mehraj, Vikram, Jenabian, Mohammad-Ali, Ponte, Rosalie, Lebouché, Bertrand, Costiniuk, Cecilia, Thomas, Réjean, Baril, Jean-Guy, LeBlanc, Roger, Cox, Joseph, Tremblay, Cécile, Routy, Jean-Pierre
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2016
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4900419/ https://www.ncbi.nlm.nih.gov/pubmed/27045377 http://dx.doi.org/10.1097/QAD.0000000000001105

Ejemplares similares

Socio‐economic status and time trends associated with early ART initiation following primary HIV infection in Montreal, Canada: 1996 to 2015
por: Mehraj, Vikram, et al.
Publicado: (2018)

CXCL13 as a Biomarker of Immune Activation During Early and Chronic HIV Infection
por: Mehraj, Vikram, et al.
Publicado: (2019)

The Dynamic Role of the IL-33/ST2 Axis in Chronic Viral-infections: Alarming and Adjuvanting the Immune Response
por: Mehraj, Vikram, et al.
Publicado: (2016)

The evaluation of risk-benefit ratio for gut tissue sampling in HIV cure research
por: Mehraj, Vikram, et al.
Publicado: (2017)

Nasal Nitric Oxide Levels in HIV Infection: A Cross-Sectional Study
por: Costiniuk, Cecilia T., et al.
Publicado: (2018)

Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls
por: Ramendra, Rayoun, et al.
Publicado: (2019)

FoxP3(+) CD8 T-cells in acute HIV infection and following early antiretroviral therapy initiation
por: Yero, Alexis, et al.
Publicado: (2022)

Influence of Hepatitis C Virus Sustained Virological Response on Immunosuppressive Tryptophan Catabolism in ART-Treated HIV/HCV Coinfected Patients
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2016)

HIV induces production of IL-18 from intestinal epithelial cells that increases intestinal permeability and microbial translocation
por: Allam, Ossama, et al.
Publicado: (2018)

Immune Suppression by Myeloid Cells in HIV Infection: New Targets for Immunotherapy
por: Mehraj, Vikram, et al.
Publicado: (2014)

HIV and the Gut Microbiota, Partners in Crime: Breaking the Vicious Cycle to Unearth New Therapeutic Targets
por: Vyboh, Kishanda, et al.
Publicado: (2015)

Reversing Gut Damage in HIV Infection: Using Non-Human Primate Models to Instruct Clinical Research
por: Ponte, Rosalie, et al.
Publicado: (2016)

Influence of letermovir treatment on gut inflammation in people living with HIV on antiretroviral therapy: protocol of the open-label controlled randomised CIAO study
por: Royston, Léna, et al.
Publicado: (2023)

Dynamics and epigenetic signature of regulatory T-cells following antiretroviral therapy initiation in acute HIV infection
por: Yero, Alexis, et al.
Publicado: (2021)

Oral cannabinoids in people living with HIV on effective antiretroviral therapy: CTN PT028—study protocol for a pilot randomised trial to assess safety, tolerability and effect on immune activation
por: Costiniuk, Cecilia T, et al.
Publicado: (2019)

The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy – CTN PT006: study protocol for a randomized controlled trial
por: Lebouché, Bertrand, et al.
Publicado: (2014)

Plasma Level of Soluble ST2 in Chronically Infected HIV-1 Patients with Suppressed Viremia
por: Younas, Mehwish, et al.
Publicado: (2017)

The Kynurenine Pathway Is a Double-Edged Sword in Immune-Privileged Sites and in Cancer: Implications for Immunotherapy
por: Routy, Jean-Pierre, et al.
Publicado: (2016)

HIV persistence in mucosal CD4(+) T cells within the lungs of adults receiving long-term suppressive antiretroviral therapy
por: Costiniuk, Cecilia T., et al.
Publicado: (2018)

The Relationship between Visceral Adiposity and Nonalcoholic Fatty Liver Disease Diagnosed by Controlled Attenuation Parameter in People with HIV: A Pilot Study
por: Sebastiani, Giada, et al.
Publicado: (2022)

Tryptophan Catabolism in Chronic Viral Infections: Handling Uninvited Guests
por: Mehraj, Vikram, et al.
Publicado: (2015)

Potential contribution of gut microbiota and systemic inflammation on HIV vaccine effectiveness and vaccine design
por: Routy, Jean-Pierre, et al.
Publicado: (2017)

The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002–2020)
por: Brenner, Bluma G., et al.
Publicado: (2021)

Kinetics of HIV-1 CTL Epitopes Recognized by HLA I Alleles in HIV-Infected Individuals at Times near Primary Infection: The Provir/Latitude45 Study
por: Papuchon, Jennifer, et al.
Publicado: (2014)

Effect of metformin on the size of the HIV reservoir in non-diabetic ART-treated individuals: single-arm non-randomised Lilac pilot study protocol
por: Routy, Jean-Pierre, et al.
Publicado: (2019)

The grace of aging with ART: Ex vivo dendritic cell-based immunotherapy restores HIV-specific functional CD8(+) T-cells
por: Mehraj, Vikram, et al.
Publicado: (2022)

Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2013)

Correction: Distinct Tryptophan Catabolism and Th17/Treg Balance in HIV Progressors and Elite Controllers
por: Jenabian, Mohammad-Ali, et al.
Publicado: (2014)

Acute inflammation and pathogenesis of SARS-CoV-2 infection: Cannabidiol as a potential anti-inflammatory treatment?
por: Costiniuk, Cecilia T., et al.
Publicado: (2020)

Safety and Tolerability of Oral Cannabinoids in People Living with HIV on Long-Term ART: A Randomized, Open-Label, Interventional Pilot Clinical Trial (CTNPT 028) †
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2022)

Camu Camu effects on microbial translocation and systemic immune activation in ART-treated people living with HIV: protocol of the single-arm non-randomised Camu Camu prebiotic pilot study (CIHR/CTN PT032)
por: Isnard, Stéphane, et al.
Publicado: (2022)

Interleukin-1β Triggers p53-Mediated Downmodulation of CCR5 and HIV-1 Entry in Macrophages through MicroRNAs 103 and 107
por: Lodge, Robert, et al.
Publicado: (2020)

Plasma Indoleamine 2,3-Dioxygenase Activity Is Associated With the Size of the Human Immunodeficiency Virus Reservoir in Patients Receiving Antiretroviral Therapy
por: Chen, Jun, et al.
Publicado: (2019)

Use of various immunotherapies for refractory ulcerative colitis in a person living with HIV: a case report
por: Costiniuk, Cecilia T, et al.
Publicado: (2021)

Pulmonary Immune Dysregulation and Viral Persistence During HIV Infection
por: Alexandrova, Yulia, et al.
Publicado: (2022)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

Antibody-Dependent Cellular Cytotoxicity-Competent Antibodies against HIV-1-Infected Cells in Plasma from HIV-Infected Subjects
por: Dupuy, Franck P., et al.
Publicado: (2019)

Evaluation of a project to engage patients in the development of a patient‐reported measure for HIV care (the I‐Score Study)
por: Lessard, David, et al.
Publicado: (2018)

Effects of Oral Cannabinoids on Systemic Inflammation and Viral Reservoir Markers in People with HIV on Antiretroviral Therapy: Results of the CTN PT028 Pilot Clinical Trial
por: Mboumba Bouassa, Ralph-Sydney, et al.
Publicado: (2023)

Quantifying Anti-HIV Envelope-Specific Antibodies in Plasma from HIV Infected Individuals
por: Kant, Sanket, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_9clp3ug35d67psdoe7iqvn81do